ERYTHEMA
Clinical trials for ERYTHEMA explained in plain language.
Never miss a new study
Get alerted when new ERYTHEMA trials appear
Sign up with your email to follow new studies for ERYTHEMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Immune booster shows promise for Hard-to-Treat breast cancers
Disease control OngoingThis study tests a drug called pembrolizumab in people with advanced inflammatory breast cancer or triple-negative breast cancer that has spread. Participants had already responded to or stabilized with chemotherapy. The drug helps the immune system attack cancer cells, and the g…
Matched conditions: ERYTHEMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 20, 2026 11:55 UTC
-
New drug combo battle against Fast-Moving breast cancer
Disease control OngoingThis study compares two different chemotherapy combinations given before surgery for a fast-growing, hard-to-treat type of breast cancer called triple-negative inflammatory breast cancer. Researchers want to see if adding a targeted drug called panitumumab to standard chemotherap…
Matched conditions: ERYTHEMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Apr 20, 2026 16:14 UTC